Mirtazapine Tablet, Film Coated
Product Images NDC 70518-2819

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-2819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Mirtazapine 7.5mg 70518 2819 01)

Mirtazapine 7.5 mg film-coated tablet single-unit packaging label. The label shows the dosage strength (7.5 mg), dosage form (tablet), and quantity (1). It is labeled for prescription use only (RX ONLY) and includes repackager information: RemedyRepack Inc., Indiana, PA. Manufacturer is Rising Pharma, Inc., Allendale, NJ. Additional details include storage instructions and a QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Mirtazapine 7.5 mg film coated tablets packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-2819-00 and repackaging information by RemedyRepack Inc. It also states the manufacturer as Rising Pharma, Inc., Allendale, NJ, with storage instructions and a QR code in the upper right corner.*

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure of mirtazapine, the active ingredient in the product. The diagram shows the molecular framework with nitrogen atoms and a methyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.